Quality of Life Assessment: Key Issues in the 1990sIt was over five years ago that the Centre for Medicines Research organized a workshop entitled "Quality of Life: Assessment and Application". This workshop brought together a unique group of participants, some of whom had been involved in studies on quality of life for well over a decade, whilst others were meeting the subject for the first time. This blend of experienced researchers and enthusiastic newcomers was a great stimulus to the discus sions which followed individual presentations as well as that resulting from the study groups. In the ensuing publication, a balance was sought between a consideration of the complex principles underlying the assessment of quality of life and the application of such assessments to specific clinical conditions which necessitated this approach. The organization in 1991 of a second workshop entitled "Quality of Life Assessment: Key Issues in the 1990s" resulted in a further consideration of the quality of life philosophy, concepts and key instruments together with an update on assessing quality of life in a number of major disease areas. Of particular importance was an examination of various viewpoints concerned with ethical questions and their implications, and quality oflife from industry, regulatory and health care purchasers' perspectives. As a result of this second workshop, the editors of the original book referred to above decided to produce a second edition with a number of updates and additional chapters. |
From inside the book
Results 1-5 of 100
Page viii
This workshop brought together a unique group of participants, some of whom had been involved in studies on quality of life ... to the discussions which followed individual presentations as well as that resulting from the study groups.
This workshop brought together a unique group of participants, some of whom had been involved in studies on quality of life ... to the discussions which followed individual presentations as well as that resulting from the study groups.
Page xi
In 1974 he joined the San Diego group headed by Jim Bush and has continued to collaborate with Dr Kaplan on the development ... She is member of several working international working groups on instrument development and is interested in ...
In 1974 he joined the San Diego group headed by Jim Bush and has continued to collaborate with Dr Kaplan on the development ... She is member of several working international working groups on instrument development and is interested in ...
Page xiii
J R Johnson, MD, is Head of the Oncology Drugs Group at the Unites States Food and Drug Administration. His responsibilities include evaluation of applications for testing and marketing of drugs for the treatment and prevention of ...
J R Johnson, MD, is Head of the Oncology Drugs Group at the Unites States Food and Drug Administration. His responsibilities include evaluation of applications for testing and marketing of drugs for the treatment and prevention of ...
Page xv
At present he is the Convenor of the EuroQol Group. His other research fields are dental economics and economic assessment of health care technologies. Professor G Teeling Smith, OBE, BA, FRPharmS, Hon MPharm, has been the Director of ...
At present he is the Convenor of the EuroQol Group. His other research fields are dental economics and economic assessment of health care technologies. Professor G Teeling Smith, OBE, BA, FRPharmS, Hon MPharm, has been the Director of ...
Page xvi
This was followed by eight years with Glaxo Group Research in the UK where he had international responsibility for several of their clinical research programmes. His current research interests include studies into the process of ...
This was followed by eight years with Glaxo Group Research in the UK where he had international responsibility for several of their clinical research programmes. His current research interests include studies into the process of ...
What people are saying - Write a review
We haven't found any reviews in the usual places.
Contents
11 | |
22 | |
rationale for a single | 65 |
Development testing and use of the Sickness Impact | 95 |
The Nottingham Health Profile | 111 |
an update | 131 |
A health index and output measure | 151 |
life 15D and its applications | 185 |
Measuring the quality of life of patients with Parkinsons | 289 |
Measuring quality of life in hypertension | 321 |
Measuring quality of life in psychiatry | 343 |
R B Joyce | 373 |
Industry perspectives on quality of life | 383 |
A regulatory view | 393 |
The cost effectiveness of pharmaceuticals | 401 |
Requirements for health care purchasers | 413 |
A WHO method for the assessment of healthrelated | 201 |
The OnLine Guide to QualityofLife Assessment | 221 |
Assessing Quality of Life in Major Disease Areas | 235 |
Measuring the quality of life of patients with rheumatoid | 269 |
The importance of quality of life in policy decisions | 427 |
Appendices | 441 |
Other editions - View all
Quality of Life Assessment: Key Issues in the 1990s S R Walker,Rachel M Rosser No preview available - 1992 |
Quality of Life Assessment: Key Issues in the 1990s S.R. Walker,Rachel M. Rosser No preview available - 2012 |
Common terms and phrases
ACE inhibitors activities airways disease analysis angina antihypertensive application areas Assessment of Quality asthma atenolol auranofin behaviour benefits Bergner cancer patients captopril chronic cilazapril clinical trials clinician compared comparison components concepts coronary correlation cost depression dimensions disability distress domains drug dysfunction effects evaluation example factors function scores groups health services health status measures health-related quality hospital hypertension illness impairment important improvement indicators individual instrument interventions interview investigator Kaplan levodopa measure of health measurement of quality medicine methodological methods methyldopa mobility morbidity mortality nifedipine outcome overall pain Parkinson's disease performance physical function population problems propranolol psychiatric psychological psychometric psychosocial QALY questionnaire reliability respiratory response rheumatoid arthritis Rosser self-administered sensitivity Sickness Impact Profile side-effects SIP score specific standard standard gamble statistical surgery symptoms Table tests therapy treatment validity valuation verapamil weights well-being well-years